EUVIMEDObjevte EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Beyond PEG: Emerging Polymer Lipid Alternatives for Lipid Nanoparticle (LNP) Formulations

Zihnil A I Mazrad, Yi Ju iD, Stephen J Kent iD, Colin W Pouton, Kristian Kempe iD

Advanced Science · 2026-09 · 13 (50)

DOI: 10.1002/advs.77145 ↗

At a glance

Übersichtsarbeit in Advanced Science, published online on 2026-08-12. Written by Zihnil A I Mazrad and 4 co-authors. Institution: Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia. Major MEDLINE topics: Polyethylene Glycols, Nanoparticles, Lipids, Polymers. Cited 7 times so far (Crossref); 100 references. The full text is freely available (open access, CC BY 4.0). Funded by: Australian Research Council, Australian Government MRFF, National Health and Medical Research Council.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Lipid nanoparticles (LNPs) have rapidly emerged as the leading delivery platform for nucleic acid therapeutics due to their high encapsulation efficiency, scalable manufacturing, and clinical success in siRNA and mRNA medicines. Poly(ethylene glycol)‐lipids ((PEG)–lipids) have been central to this progress by providing steric stabilization, size control, and tunable biodistribution. However, PEGylation also introduces important limitations, including complement activation, pre‐existing and treatment‐induced anti‐PEG antibodies, and accelerated blood clearance, which increasingly constrain repeated and long‐term dosing strategies. This review focuses on recent advances in PEG‐alternative LNP designs, including non‐PEG polymers, zwitterionic and biomimetic lipids, polypeptides, and structurally modified PEG analogues. We compare how polymer chemistry, anchor geometry, and grafting architecture influence LNP formation, physicochemical properties, biodistribution, cellular uptake, and immunological outcomes. Moreover, we discuss key challenges that remain in translating PEG‐free and PEG‐modified LNPs toward clinical application and propose future directions to better understand in vivo behavior and enable rational design of next‐generation stealth LNPs. Overall, PEG lipid alternatives should not be viewed as simple PEG mimics, but as distinct surface‐engineering materials that create new nano‐bio interfaces and reshape LNP behavior in biological systems.

Subjects

MeSH terms (MEDLINE)

Polyethylene GlycolsNanoparticlesLipidsPolymersDrug Delivery SystemsHumansAnimalsTissue DistributionLiposomes

Author keywords

Poly(ethylene glycol) alternativeslipid nanoparticlesmRNAnanomedicinesstealth polymers

Substances

Polyethylene GlycolsLipidsPolymersLipid NanoparticlesLiposomes

Authors and institutions

  • Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
  • Materials Science and Engineering, Monash University, Clayton, Victoria, Australia.
  • Olivia Newton-John Cancer Research Institute, and School of Cancer Medicine, La Trobe University, Heidelberg, Victoria, Australia.
  • Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
  • Melbourne Sexual Health Centre and Department of Infectious Diseases, Alfred Hospital and Central Clinical School, Monash University, Melbourne, Victoria, Australia.

ORCID profiles: Yi Ju, Stephen J Kent, Kristian Kempe

Funding

  • Australian Research Council
  • Australian Government MRFF
  • National Health and Medical Research Council

Cite

APA

Mazrad, Z. A. I., Ju, Y., Kent, S. J., Pouton, C. W., & Kempe, K. (2026). Beyond PEG: Emerging Polymer Lipid Alternatives for Lipid Nanoparticle (LNP) Formulations. Advanced Science, 13(50). https://doi.org/10.1002/advs.77145

Vancouver

Mazrad ZAI, Ju Y, Kent SJ, Pouton CW, Kempe K. Beyond PEG: Emerging Polymer Lipid Alternatives for Lipid Nanoparticle (LNP) Formulations. Advanced Science. 2026;13(50). doi:10.1002/advs.77145

BibTeX
@article{Mazrad2026,
  author = {Mazrad, Zihnil A I and Ju, Yi and Kent, Stephen J and Pouton, Colin W and Kempe, Kristian},
  title = {Beyond PEG: Emerging Polymer Lipid Alternatives for Lipid Nanoparticle (LNP) Formulations},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {50},
  doi = {10.1002/advs.77145}
}
Start for free →